Allergy Therapeutics Stock Quote AGY - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
UK
LSE
Allergy Therapeutics Plc (AGY) Quote

Allergy Therapeutics Plc (AGY)

5.45

-0.15

( -2.68% )

Updated: 03:00:00

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

5.45

Bid

5.20

Ask

5.70

Volume

225,148

5.45 Day's Range 5.45

1.275 52 Week Range 6.05

Market Cap

Previous Close

5.60

Open

5.45

Last Trade

Last Trade Time

06:47:30

Financial Volume

-

VWAP

-

Average Volume (3m)

900,089

Shares Outstanding

4,766,439,938

Dividend Yield

-

PE Ratio

-6.06

Earnings Per Share (EPS)

-0.01

Revenue

59.59M

Net Profit

-43.07M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.allergytherapeutics.com

Headquarters

West Sussex, Gbr

Founded

1970

Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 5.60p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 1.275p to 6.05p.

Allergy Therapeutics currently has 4,766,439,938 shares outstanding. The market capitalization of Allergy Therapeutics is £266.92 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -6.06.

Allergy Therapeutics PLC Trading update for the year ended 30 June 2024

Allergy Therapeutics PLC 22 July 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company" or the "Group") Trading update for the year ended 30 June 2024 - Financial...

Allergy Therapeutics PLC Appointment of Nominated Adviser and Sole Broker

Allergy Therapeutics PLC 22 July 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company" or the "Group") Appointment of Nominated Adviser and Corporate Broker 22 July...

Allergy Therapeutics PLC Launch of new Company Long Term Incentive Plan

Allergy Therapeutics PLC 04 July 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Launch of new Company Long Term Incentive Plan Grant of Options Change of...

Allergy Therapeutics PLC Appointment of Non-Executive Director

Allergy Therapeutics PLC 27 June 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Directorate Change Appointment of David Ball as Non-Executive Director 27...

Allergy Therapeutics welcomes peanut allergy vaccine trial results

Allergy Therapeutics PLC on Monday hailed positive findings from trial results for a peanut allergy vaccine. Shares ...

Allergy Therapeutics PLC Progression of patient cohorts in PROTECT Trial

Allergy Therapeutics PLC 10 June 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics announces progression through patient cohorts in Phase I/IIa...

Allergy Therapeutics PLC Successful meetings with Paul Ehrlich Institut

Allergy Therapeutics PLC 03 June 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics announces successful meetings with Paul Ehrlich Institut to...

Allergy Therapeutics PLC Allergy Therapeutics presents findings at EAACI

Allergy Therapeutics PLC 31 May 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics presents scientific findings from research portfolio at...

TRADING UPDATES: Abingdon Health buys IVDeology Holdings

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.05	-0.909090909091	5.5	5.7	5.35	426710	5.54876505	DE
4	0.2	3.80952380952	5.25	5.7	4.555	494683	5.33021188	DE
12	2.6	91.2280701754	2.85	6.05	2.8	900089	4.55578104	DE
26	3.1	131.914893617	2.35	6.05	1.88	818352	3.64720819	DE
52	3.4	165.853658537	2.05	6.05	1.275	974053	2.73331349	DE
156	-20.55	-79.0384615385	26	40	0.85	609840	6.98525177	DE
260	-6.3	-53.6170212766	11.75	40	0.85	477723	9.53350177	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SERVServe Robotics Inc	$ 11.90 (57.62%)	12.66M
NCPLNetcapital Inc	$ 0.1435 (37.98%)	17.83M
CISOCISO Global Inc	$ 0.7725 (29.83%)	1.16M
RRRichtech Robotics Inc	$ 1.90 (29.25%)	6.01M
NUZENuZee Inc	$ 1.35 (18.54%)	667
XCURExicure Inc	$ 0.4017 (-24.93%)	125.67k
VVOSVivos Therapeutics Inc	$ 2.05 (-16.33%)	1
NVOSNovo Integrated Sciences Inc	$ 0.5711 (-14.12%)	127.11k
SNTGSentage Holdings Inc	$ 2.13 (-14.11%)	17.71k
SNOASonoma Pharmaceuticals Inc	$ 0.265 (-13.96%)	540
NCPLNetcapital Inc	$ 0.1435 (37.98%)	17.83M
SERVServe Robotics Inc	$ 11.90 (57.62%)	12.66M
RRRichtech Robotics Inc	$ 1.90 (29.25%)	6.01M
SQQQProShares UltraPro Short QQQ	$ 8.25 (-2.48%)	2.02M
MAXNMaxeon Solar Technologies Ltd	$ 0.222 (2.97%)	2M

uranium-pinto-beans

uranium-pinto-beans 2 minutes ago

Reddit price target raised to $50 from $45 at Bernstein
Bernstein analyst Mark Shmulik raised the firm's price target on Reddit (RDDT) to $50 from $45 and keeps an Underperform rating on the shares. The firm revises up its near-term estimates tied to the OpenAI partnership announced in May, w

DesktopDR

DesktopDR 2 minutes ago

I hope Rich Inza isn't being paid. If he is, he should be fired. We need updates. We own part of the company!!!

Pnypnchr

Pnypnchr 3 minutes ago

You're absolutely right New money98, and that is why we wait for them. The chart don't lie and the bashers do not want to talk about that split for obvious reasons.

Solarman

Solarman 3 minutes ago

$MMMW great new solar cost cutting product and very low market cap.

ShireBoy2115

ShireBoy2115 5 minutes ago

$SILO $2.7 +10% could bounce hard after small offering on a red Friday took it down from $4.5 to $2.5. Had PTSD drug delivery news before offering.

Drugdoctor

Drugdoctor 6 minutes ago

Wow, 23% shares acquired - TCL Zhonghuan Renewable Energy Technology Co., Ltd. (“TZS Parent”)

https://ih.advfn.com/stock-market/NASDAQ/maxeon-solar-technologies-MAXN/stock-news/94227577/form-sc-13d-a-general-statement-of-acquisition-o

Jake731

Jake731 7 minutes ago

Good morning all.

TPTW……!!!!!!!!

PEACHMAN

PEACHMAN 8 minutes ago

IFUS discovered a way to break down lignin and create a new game changing cattle feed called SGP+

Some folks never quite got the humor of this video below. The point was that getting stuck in their old ways ranchers and farmers and feedlots to change how and what they feed their cattl

Zadie420

Zadie420 10 minutes ago

I don't think LP said is going to take 18 months to get an approval. The facility is GMP now. When the regulators ready they will visit Advent facility. This is beyond LP control. Who knows may be they already schedule to do that. I don't think NWBO is going to PR the regulator visit.

hedge_fun

hedge_fun 10 minutes ago

Today is the 5th Anniversary when it……

was first proclaimed the device works.

That same day it was also proclaimed AGAIN they were “on the wreck” at Melbourne, and we know how that turned out, don’t we?

Happy Anniversary and GL!!!

https:/

ae kusterer

ae kusterer 11 minutes ago

Nemesis18

Re: kabunushi post# 706255

Monday, July 15, 2024 5:48:34 PM

Post#
706260
of 707496
Why not contact the MHRA's CEO's Office direct then, to find out yourself ?
Or are you afraid to venture outside of this forum to s

ChannelTrader

ChannelTrader 11 minutes ago

Solarman

Solarman 12 minutes ago

Very good product.

jxyzobrien

jxyzobrien 12 minutes ago

refocus
no one knows the future

the dax does the 3am pump dump
dax up 1.4 pct i do not why or even care
again mon tues generally up
wed th fri generally down

knowing that what did the charts say
the markets job is to fool you. your

uranium-pinto-beans

uranium-pinto-beans 13 minutes ago

Amazon.com price target raised to $230 from $220 at Truist
Truist raised the firm's price target on Amazon.com to $230 from $220 and keeps a Buy rating on the shares ahead of its Q2 results next week. The firm anticipates a beat, citing its Truist Card Data that tracks North America sales, po

Solarman

Solarman 13 minutes ago

$BIXT and $MMMW both have great recent news and corporate developments.

funnytimes2

funnytimes2 14 minutes ago

KRAIG BIOCRAFT LABORATORIES FURTHER EXPANDS SPIDER SILK PRODUCTION LEVELS WITH LAUNCH OF THIRD PRODUCTION CYCLE

ANN ARBOR, Mich., – July 22, 2024– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs“), announces the launch of its third and largest production

Allergy Therapeutics

Avid Tech Inc Dl 01

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions